1	Paciente	paciente	NCCS000	C0030705	persona	0-8	282_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	9-11	282_QUEST_clinical_caseMIR	SENT1	-	-
3	57	57		-	-	12-14	282_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	15-19	282_QUEST_clinical_caseMIR	SENT1	-	-
5	,	,	Fc	-	-	19-20	282_QUEST_clinical_caseMIR	SENT1	-	-
6	diagnosticado	diagnosticar	VMP00SM	-	-	21-34	282_QUEST_clinical_caseMIR	SENT1	-	-
7	de	de	SPS00	C0332285	atributo	35-37	282_QUEST_clinical_caseMIR	SENT1	-	-
8	adenocarcinoma	adenocarcinoma	NC00SC0	C0001418	anomalía_morfológica	38-52	282_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
9	de	de	SPS00	C0332285	atributo	53-55	282_QUEST_clinical_caseMIR	SENT1	-	-
10	colon	colon	NCMS000	C0009368#C1281569	estructura_corporal	56-61	282_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
11	estadio	estadio	NCMS000	C1306673#C0442588	atributo#medio_ambiente	62-69	282_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
12	T3N1M0	T3N1M0		-	-	70-76	282_QUEST_clinical_caseMIR	SENT1	I-Calificador	-
13	.	.	Fp	-	-	76-77	282_QUEST_clinical_caseMIR	SENT1	-	-

1	Fue	ser	VSIS3S0	-	-	78-81	282_QUEST_clinical_caseMIR	SENT2	-	-
2	tratado	tratar	VMP00SM	C0332293_1	atributo_1	82-89	282_QUEST_clinical_caseMIR	SENT2	-	-
3	con	con	SPS00	C0332293_2	atributo_2	90-93	282_QUEST_clinical_caseMIR	SENT2	-	-
4	resección	resección	NCFS000	C0728940#C0547070	procedimiento	94-103	282_QUEST_clinical_caseMIR	SENT2	-	-
5	seguida	seguir	VMP00SF	-	-	104-111	282_QUEST_clinical_caseMIR	SENT2	-	-
6	de	de	SPS00	C0332285	atributo	112-114	282_QUEST_clinical_caseMIR	SENT2	-	-
7	quimioterapia	quimioterapia	NCFS000	C0392920#C0013216#C3665472	régimen/tratamiento#procedimiento	115-128	282_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
8	postoperatoria	postoperatorio	AQ0FS0	-	-	129-143	282_QUEST_clinical_caseMIR	SENT2	-	-
9	FOLFOX	folfox	AQ0CN00	-	-	144-150	282_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
10	(	(	Fpa	-	-	151-152	282_QUEST_clinical_caseMIR	SENT2	-	-
11	fluorouracilo	fluorouracilo	NC00SC0	C0016360	sustancia	152-165	282_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
12	,	,	Fc	-	-	165-166	282_QUEST_clinical_caseMIR	SENT2	-	-
13	leucovorin	leucovorin	NCCN000	-	-	167-177	282_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
14	y	y	CC	C1706368	calificador	178-179	282_QUEST_clinical_caseMIR	SENT2	-	-
15	oxaliplatino	oxaliplatino	NC00SC0	C0069717	sustancia#producto	180-192	282_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
16	)	)	Fpt	-	-	192-193	282_QUEST_clinical_caseMIR	SENT2	-	-
17	durante	durante	SPS00	C1444752#C0347984	atributo	194-201	282_QUEST_clinical_caseMIR	SENT2	-	-
18	6	6		-	-	202-203	282_QUEST_clinical_caseMIR	SENT2	-	-
19	meses	mes	NCMP000	C0439231	calificador	204-209	282_QUEST_clinical_caseMIR	SENT2	-	-
20	.	.	Fp	-	-	209-210	282_QUEST_clinical_caseMIR	SENT2	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	211-213	282_QUEST_clinical_caseMIR	SENT3	-	-
2	un	un		C0205447_1	calificador_1	214-216	282_QUEST_clinical_caseMIR	SENT3	-	-
3	control	control	NCMS000	C2587213	atributo	217-224	282_QUEST_clinical_caseMIR	SENT3	-	-
4	rutinario	rutinario	AQ0MS0	-	-	225-234	282_QUEST_clinical_caseMIR	SENT3	-	-
5	,	,	Fc	-	-	234-235	282_QUEST_clinical_caseMIR	SENT3	-	-
6	dos	dos		-	-	236-239	282_QUEST_clinical_caseMIR	SENT3	-	-
7	años	año	NCMP000	C0439234	calificador	240-244	282_QUEST_clinical_caseMIR	SENT3	-	-
8	después	después	RG	C0231290	atributo	245-252	282_QUEST_clinical_caseMIR	SENT3	-	-
9	,	,	Fc	-	-	252-253	282_QUEST_clinical_caseMIR	SENT3	-	-
10	se	se	P00CN000	-	-	254-256	282_QUEST_clinical_caseMIR	SENT3	-	-
11	detecta	detectar	VMIP3S0	-	-	257-264	282_QUEST_clinical_caseMIR	SENT3	-	-
12	elevación	elevación	NCFS000	C0439775	procedimiento	265-274	282_QUEST_clinical_caseMIR	SENT3	-	-
13	de	de	SPS00	C0332285	atributo	275-277	282_QUEST_clinical_caseMIR	SENT3	-	-
14	antígeno	antígeno	NCMS000	C0007082_1	sustancia_1	278-286	282_QUEST_clinical_caseMIR	SENT3	-	-
15	carcinoembrionario	carcinoembrionario	AQ0MS0	C0007082_2	sustancia_2	287-305	282_QUEST_clinical_caseMIR	SENT3	-	-
16	(	(	Fpa	-	-	306-307	282_QUEST_clinical_caseMIR	SENT3	-	-
17	CEA	cea	NC00YL0	-	-	307-310	282_QUEST_clinical_caseMIR	SENT3	-	-
18	)	)	Fpt	-	-	310-311	282_QUEST_clinical_caseMIR	SENT3	-	-
19	a	a	SPS00	-	-	312-313	282_QUEST_clinical_caseMIR	SENT3	-	-
20	30	30		-	-	314-316	282_QUEST_clinical_caseMIR	SENT3	-	-
21	ng	nasogástrico	NC00YL0	-	-	317-319	282_QUEST_clinical_caseMIR	SENT3	-	-
22	/	/	Fh	-	-	319-320	282_QUEST_clinical_caseMIR	SENT3	-	-
23	mL	mililitro	NCMN000	C0439242	calificador	320-322	282_QUEST_clinical_caseMIR	SENT3	-	-
24	(	(	Fpa	-	-	323-324	282_QUEST_clinical_caseMIR	SENT3	-	-
25	previo	previo	AQ0MS0	C0205156	calificador	324-330	282_QUEST_clinical_caseMIR	SENT3	-	-
26	menor	menor	AQ0CS0	C0700321#C1282918#C0205165#C0026193	calificador#persona	331-336	282_QUEST_clinical_caseMIR	SENT3	-	-
27	de	de	SPS00	C0332285	atributo	337-339	282_QUEST_clinical_caseMIR	SENT3	-	-
28	2	2		-	-	340-341	282_QUEST_clinical_caseMIR	SENT3	-	-
29	ng	nasogástrico	NC00YL0	-	-	342-344	282_QUEST_clinical_caseMIR	SENT3	-	-
30	/	/	Fh	-	-	344-345	282_QUEST_clinical_caseMIR	SENT3	-	-
31	mL	mililitro	NCMN000	C0439242	calificador	345-347	282_QUEST_clinical_caseMIR	SENT3	-	-
32	)	)	Fpt	-	-	347-348	282_QUEST_clinical_caseMIR	SENT3	-	-
33	.	.	Fp	-	-	348-349	282_QUEST_clinical_caseMIR	SENT3	-	-

1	No	no	RN	C1298908	calificador	350-352	282_QUEST_clinical_caseMIR	SENT4	-	-
2	tiene	tener	VMIP3S0	-	-	353-358	282_QUEST_clinical_caseMIR	SENT4	-	-
3	síntomas	síntoma	NCMP000	C1457887	hallazgo	359-367	282_QUEST_clinical_caseMIR	SENT4	-	-
4	,	,	Fc	-	-	367-368	282_QUEST_clinical_caseMIR	SENT4	-	-
5	el	el	DA0MS0	-	-	369-371	282_QUEST_clinical_caseMIR	SENT4	-	-
6	examen	examen	NCMS000	C0031809_1	procedimiento_1	372-378	282_QUEST_clinical_caseMIR	SENT4	-	-
7	físico	físico	NCMS000	C0031809_2	procedimiento_2	379-385	282_QUEST_clinical_caseMIR	SENT4	-	-
8	es	ser	VSIP3S0	-	-	386-388	282_QUEST_clinical_caseMIR	SENT4	-	-
9	anodino	anodino	AQ0MS0	-	-	389-396	282_QUEST_clinical_caseMIR	SENT4	-	-
10	,	,	Fc	-	-	396-397	282_QUEST_clinical_caseMIR	SENT4	-	-
11	la	el	DA0FS0	-	-	398-400	282_QUEST_clinical_caseMIR	SENT4	-	-
12	radiografía	radiografía	NCFS000	C0039985_1	procedimiento_1	401-412	282_QUEST_clinical_caseMIR	SENT4	-	-
13	de	de	SPS00	C0039985_2	procedimiento_2	413-415	282_QUEST_clinical_caseMIR	SENT4	-	-
14	tórax	tórax	NCMN000	C0039985_3	procedimiento_3	416-421	282_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
15	es	ser	VSIP3S0	-	-	422-424	282_QUEST_clinical_caseMIR	SENT4	-	-
16	normal	normal	AQ0CS0	C0205307	calificador	425-431	282_QUEST_clinical_caseMIR	SENT4	-	-
17	.	.	Fp	-	-	431-432	282_QUEST_clinical_caseMIR	SENT4	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	433-435	282_QUEST_clinical_caseMIR	SENT5	-	-
2	la	el	DA0FS0	-	-	436-438	282_QUEST_clinical_caseMIR	SENT5	-	-
3	TC	símbolo_químico_del_tecnecio	NC00YL0	-	-	439-441	282_QUEST_clinical_caseMIR	SENT5	-	-
4	se	se	P00CN000	-	-	442-444	282_QUEST_clinical_caseMIR	SENT5	-	-
5	aprecia	apreciar	VMIP3S0	-	-	445-452	282_QUEST_clinical_caseMIR	SENT5	-	-
6	una	una		C0205447_1	calificador_1	453-456	282_QUEST_clinical_caseMIR	SENT5	-	-
7	masa	masa	NCFS000	C1306372#C0577559	calificador#hallazgo#anomalía_morfológica	457-461	282_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	-
8	de	de	SPS00	C0332285	atributo	462-464	282_QUEST_clinical_caseMIR	SENT5	-	-
9	3	3	Z	-	-	465-466	282_QUEST_clinical_caseMIR	SENT5	-	-
10	cm	cm	NCMN000	-	-	467-469	282_QUEST_clinical_caseMIR	SENT5	-	-
11	en	en	SPS00	C1720294#C0332285	calificador#atributo	470-472	282_QUEST_clinical_caseMIR	SENT5	-	-
12	el	el	DA0MS0	-	-	473-475	282_QUEST_clinical_caseMIR	SENT5	-	-
13	lóbulo	lóbulo	NCMS000	C0227481_1	estructura_corporal_1	476-482	282_QUEST_clinical_caseMIR	SENT5	B-Estructura_Corporal	-
14	hepático	hepático	AQ0MS0	C0227481_2	estructura_corporal_2	483-491	282_QUEST_clinical_caseMIR	SENT5	I-Estructura_Corporal	-
15	derecho	derecho	NCMS000	C0227481_3	estructura_corporal_3	492-499	282_QUEST_clinical_caseMIR	SENT5	I-Estructura_Corporal	-
16	que	que	PR0CN000	-	-	500-503	282_QUEST_clinical_caseMIR	SENT5	-	-
17	capta	captar	VMIP3S0	-	-	504-509	282_QUEST_clinical_caseMIR	SENT5	-	-
18	en	en	SPS00	C1720294#C0332285	calificador#atributo	510-512	282_QUEST_clinical_caseMIR	SENT5	-	-
19	PET	positron_emission_tomography_(tomografía_por_emisión_de_positrones)	NC00YL0	-	-	513-516	282_QUEST_clinical_caseMIR	SENT5	-	-
20	.	.	Fp	-	-	516-517	282_QUEST_clinical_caseMIR	SENT5	-	-

1	No	no	RN	C1298908	calificador	518-520	282_QUEST_clinical_caseMIR	SENT6	-	-
2	se	se	P00CN000	-	-	521-523	282_QUEST_clinical_caseMIR	SENT6	-	-
3	observan	observar	VMIP3P0	-	-	524-532	282_QUEST_clinical_caseMIR	SENT6	-	-
4	otras	otro	DI0FP0	C0205394#C0449210	calificador#estructura_corporal	533-538	282_QUEST_clinical_caseMIR	SENT6	-	-
5	alteraciones	alteración	NCFP000	-	-	539-551	282_QUEST_clinical_caseMIR	SENT6	-	-
6	en	en	SPS00	C1720294#C0332285	calificador#atributo	552-554	282_QUEST_clinical_caseMIR	SENT6	-	-
7	TC	símbolo_químico_del_tecnecio	NC00YL0	-	-	555-557	282_QUEST_clinical_caseMIR	SENT6	-	-
8	ni	ni	CC	-	-	558-560	282_QUEST_clinical_caseMIR	SENT6	-	-
9	en	en	SPS00	C1720294#C0332285	calificador#atributo	561-563	282_QUEST_clinical_caseMIR	SENT6	-	-
10	PET	positron_emission_tomography_(tomografía_por_emisión_de_positrones)	NC00YL0	-	-	564-567	282_QUEST_clinical_caseMIR	SENT6	-	-
11	.	.	Fp	-	-	567-568	282_QUEST_clinical_caseMIR	SENT6	-	-

1	¿	¿	Fia	-	-	569-570	282_QUEST_clinical_caseMIR	SENT7	-	-
2	Qué	qué	DT0CN0	-	-	570-573	282_QUEST_clinical_caseMIR	SENT7	-	-
3	actitud	actitud	NCFS000	C0004271	entidad_observable	574-581	282_QUEST_clinical_caseMIR	SENT7	-	-
4	le	le	PP3CSD00	C1292157#C0409974	hallazgo#trastorno	582-584	282_QUEST_clinical_caseMIR	SENT7	-	-
5	parece	parecer	VMIP3S0	-	-	585-591	282_QUEST_clinical_caseMIR	SENT7	-	-
6	más	más	RG	C0205172	calificador	592-595	282_QUEST_clinical_caseMIR	SENT7	-	-
7	correcta	correcto	AQ0FS0	C0205170	calificador	596-604	282_QUEST_clinical_caseMIR	SENT7	-	-
8	?	?	Fit	-	-	604-605	282_QUEST_clinical_caseMIR	SENT7	-	-
9	.	.	Fp	-	-	605-606	282_QUEST_clinical_caseMIR	SENT7	-	-

